Can analysts adopt a bullish outlook for Colgate-Palmolive Company (NYSE:CL)?

November 10, 2018 - By Winifred Garcia

Investors sentiment increased to 0.81 in Q2 2018. Its up 0.12, from 0.69 in 2018Q1. It is positive, as 62 investors sold Colgate-Palmolive Company shares while 438 reduced holdings. 88 funds opened positions while 317 raised stakes. 612.32 million shares or 1.21% more from 605.00 million shares in 2018Q1 were reported.
Davy Asset Mgmt Ltd holds 35,675 shares or 0.88% of its portfolio. Webster Savings Bank N A has invested 0.03% in Colgate-Palmolive Company (NYSE:CL). Mcrae Capital Mgmt Inc reported 3,700 shares. Whittier reported 0.29% in Colgate-Palmolive Company (NYSE:CL). Flossbach Von Storch Ag holds 1.76M shares or 1.12% of its portfolio. Fuller And Thaler Asset Incorporated owns 0% invested in Colgate-Palmolive Company (NYSE:CL) for 6,200 shares. Reynders Mcveigh Mngmt Limited Liability Corporation invested 0.07% of its portfolio in Colgate-Palmolive Company (NYSE:CL). The New Jersey-based Abner Herrman And Brock has invested 0.16% in Colgate-Palmolive Company (NYSE:CL). Badgley Phelps Bell owns 124,759 shares for 0.6% of their portfolio. Bragg Financial Advsrs invested in 36,464 shares. Texas-based Cullen Frost Bankers has invested 0.1% in Colgate-Palmolive Company (NYSE:CL). The New Jersey-based Pathstone Family Office Lc has invested 0.01% in Colgate-Palmolive Company (NYSE:CL). Transamerica Fincl Advsr invested in 1,909 shares. Cibc Asset Mgmt Incorporated invested 0.04% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Provident reported 0.11% of its portfolio in Colgate-Palmolive Company (NYSE:CL).

Since May 14, 2018, it had 0 insider purchases, and 9 selling transactions for $14.53 million activity. Shotts Philip G. had sold 462 shares worth $30,978 on Tuesday, September 11. The insider MOISON FRANCK J sold $978,572. $737,863 worth of Colgate-Palmolive Company (NYSE:CL) was sold by Deoras Mukul. Another trade for 19,500 shares valued at $1.20 million was made by Marsili Daniel B on Tuesday, May 15. Wallace Noel R. had sold 46,009 shares worth $2.85 million on Monday, May 14. JAKOBSEN HENNING I sold $68,060 worth of stock.

Colgate-Palmolive Company (NYSE:CL) Ratings Coverage

Among 11 analysts covering Colgate-Palmolive (NYSE:CL), 2 have Buy rating, 1 Sell and 8 Hold. Therefore 18% are positive. Colgate-Palmolive had 15 analyst reports since May 24, 2018 according to SRatingsIntel. Macquarie Research downgraded the stock to “Neutral” rating in Monday, July 30 report. The company was downgraded on Monday, October 29 by SunTrust. Argus Research maintained the stock with “Buy” rating in Tuesday, October 30 report. The firm has “Neutral” rating by Citigroup given on Tuesday, July 31. JP Morgan downgraded it to “Underweight” rating and $54 target in Monday, October 29 report. Argus Research maintained Colgate-Palmolive Company (NYSE:CL) on Tuesday, September 18 with “Buy” rating. As per Wednesday, October 17, the company rating was maintained by Wells Fargo. Citigroup maintained Colgate-Palmolive Company (NYSE:CL) on Monday, October 29 with “Neutral” rating. Argus Research upgraded the shares of CL in report on Friday, May 25 to “Buy” rating. The rating was maintained by Wells Fargo with “Market Perform” on Monday, October 29. Below is a list of Colgate-Palmolive Company (NYSE:CL) latest ratings and price target changes.

30/10/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $75 New Target: $70 Maintain
29/10/2018 Broker: SunTrust Old Rating: Buy New Rating: Hold Old Target: $80 New Target: $65 Downgrade
29/10/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $62 New Target: $58 Maintain
29/10/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $68 New Target: $63 Maintain
29/10/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Underweight Old Target: $61 New Target: $54 Downgrade
17/10/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $64 New Target: $62 Maintain
20/09/2018 Broker: Atlantic Securities Rating: Neutral New Target: $71 Initiates Coverage On
18/09/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $72 New Target: $75 Maintain
31/07/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $70 New Target: $68 Maintain
30/07/2018 Broker: Macquarie Research Old Rating: Outperform New Rating: Neutral Downgrade

The stock increased 4.76% or $2.9 during the last trading session, reaching $63.8. About 9.74 million shares traded or 140.71% up from the average. Colgate-Palmolive Company (NYSE:CL) has declined 5.52% since November 10, 2017 and is downtrending. It has underperformed by 21.14% the S&P500.

Colgate-Palmolive Company, together with its subsidiaries, makes and sells consumer products worldwide. The company has market cap of $55.34 billion. It operates through two divisions, Oral, Personal and Home Care; and Pet Nutrition. It has a 25.54 P/E ratio. The firm offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, and other related products.

More recent Colgate-Palmolive Company (NYSE:CL) news were published by: Seekingalpha.com which released: “Colgate Shares Remain Pricey Despite Their Drop” on October 30, 2018. Also Finance.Yahoo.com published the news titled: “Stocks – Dow Skids on Global Growth Concerns, but Posts Solid Weekly Gain” on November 10, 2018. Benzinga.com‘s news article titled: “Analysts Turn Bearish On Colgate-Palmolive” with publication date: October 29, 2018 was also an interesting one.

Colgate-Palmolive Company (NYSE:CL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>